Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fortin

Showing results (191-200 of 329) with videos related to

Pageof 33
Sort By:
The Journal of Rheumatology|April 17, 2009
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohortChristine A Peschken, Steven J Katz, Earl Silverman, et al.
The Journal of Rheumatology|December 17, 2010
Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritisElaheh Aghdassi, Wendy Zhang, Yvan St-Pierre, et al.
Arthritis and Rheumatism|December 17, 2002
Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or kneePaul R Fortin, John R Penrod, Ann E Clarke, et al.
Lupus Science & Medicine|April 27, 2026
Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohortMegan R W Barber, Yvan St Pierre, Christine A Peschken, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
The Journal of Rheumatology|November 28, 2000
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, J Penrod, Y St Pierre, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2007
Lung cancer in systemic lupus erythematosusJ Bin, S Bernatsky, C Gordon, et al.
The Journal of Rheumatology|January 15, 2023
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory DiseasesGlen S Hazlewood, Ines Colmegna, Carol Hitchon, et al.
Rheumatology (Oxford, England)|June 3, 2004
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcomeA E Clarke, M Petri, S Manzi, et al.
Rheumatology (Oxford, England)|June 27, 2025
An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trialJoo-Young Esther Lee, Arielle Mendel, Isabelle Malhamé, et al.
Pageof 33

Showing results (191-200 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Rheumatology|April 17, 2009
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohortChristine A Peschken, Steven J Katz, Earl Silverman, et al.
The Journal of Rheumatology|December 17, 2010
Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritisElaheh Aghdassi, Wendy Zhang, Yvan St-Pierre, et al.
Arthritis and Rheumatism|December 17, 2002
Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or kneePaul R Fortin, John R Penrod, Ann E Clarke, et al.
Lupus Science & Medicine|April 27, 2026
Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohortMegan R W Barber, Yvan St Pierre, Christine A Peschken, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
The Journal of Rheumatology|November 28, 2000
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, J Penrod, Y St Pierre, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2007
Lung cancer in systemic lupus erythematosusJ Bin, S Bernatsky, C Gordon, et al.
The Journal of Rheumatology|January 15, 2023
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory DiseasesGlen S Hazlewood, Ines Colmegna, Carol Hitchon, et al.
Rheumatology (Oxford, England)|June 3, 2004
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcomeA E Clarke, M Petri, S Manzi, et al.
Rheumatology (Oxford, England)|June 27, 2025
An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trialJoo-Young Esther Lee, Arielle Mendel, Isabelle Malhamé, et al.
Pageof 33